PDCD1 and melanoma: In addition, studies have shown that the abundance of circulatory PD-1+ Tregs (Regulatory T cells) is rapidly decreased, the development of melanoma is significantly inhibited and the risk of metastasis is significantly reduced after anti-PD-1 therapy [52].